Justification for the lack of ISR data [Bioanalytics]

posted by Dr Andrew Leary – Ireland, 2013-03-18 10:52 (4454 d 12:37 ago) – Posting: # 10217
Views: 4,756

Dear All

I expect that many of you will have come across regulators who apply current bioanalytical guidelines to studies which were completed prior to 2011, without ISR.

The PKWP Q&A document from 10 DEC 2012 suggests that scientific justification for the lack of ISR might include taking into consideration "the width of the 90% confidence interval and the ratio to possibly justify that a false positive outcome due to ISR problems has a low probability".

Any ideas as to exactly how this might be achieved? :confused:

KR

Andrew Leary

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
58 visitors (0 registered, 58 guests [including 9 identified bots]).
Forum time: 00:30 CEST (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5